RusNano, Domain Associates agree to set up pharma facility in Russia
Expected to be commissioned by 2015, the new pharma plant project will focus on the production of new drugs and may have a capacity of about 200 million
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
Delivering corrective measures in real-time, the critical modules loaded Goose Quality Manager assists in dealing with non-conformances, internal and external audits, change management, corrective action and preventive action